Abstract Abnormal expression of cyclin-dependent kinase 2 (CDK2)/cyclin-E is detected in colorectal, ovarian, breast and prostate cancers. The study of CDK2 with a bound inhibitor revealed CDK2 as a potential therapeutic target for several proliferative diseases. Several highly selective inhibitors of CDK2 are currently undergoing clinical trials, but possibilities remain for the identification and development of novel and improved inhibitors. For example, in silico targeting of ATP-competitive inhibitors of CDKs is of special interest. A series of 3,5-diaminoindazoles was studied using molecular docking and comparative field analyses. We used post-docking short time molecular dynamics (MD) simulation to account for receptor flexibility. The three types of structures, i.e., the highest energy, lowest energy and the structure most resembling the X-ray structure (three complexes) were identified for all ligands. QM/MM energy calculations were performed using a DFT b3lyp/6–31 g* and MM OPLS-2005 force field. Conceptual DFT properties such as the interaction energy of ligand to protein, global hardness (η), HOMO density, electrostatic potential, and electron density were calculated and related to inhibitory activity. CoMFA and CoMSIA were used to account for steric and electrostatic interactions. The results of this study provide insight into the bioactive conformation, interactions involved, and the effect of different drug fragments over different biological activities.
electrostatic interactions0.9948986852367373^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Intermolecular_force  

clinical trials               0.9999999984186161^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Clinical_trial        

electrostatic potential       0.9999983741051467^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Electrostatics        

CDK2                          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cyclin-dependent_kinase_2

energy                        0.9999999999997726^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Energy                

prostate cancers              1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Prostate_cancer       

expression                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Gene_expression       

MD                            0.7861232600896247^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Physician             

steric                        0.9999999994408881^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Steric_effects        

inhibitors                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Enzyme_inhibitor      

energy                        0.9999999999997726^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Energy                

ligands                       0.9999852954364284^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Ligand                

bioactive                     0.9997039339340725^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Biological_activity   

molecular dynamics            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Molecular_dynamics    

protein                       0.9999999885080798^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Protein               

biological activities         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Biological_activity   

electron density              0.9999973434015645^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Electron_density      

drug                          0.9999755514105462^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Drug                  

DFT                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Density_functional_theory

breast                        0.9999999947367542^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Breast_cancer         

CDKs                          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cyclin-dependent_kinase

density                       0.5529944703037296^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Electron_density      

QM/MM                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/QM/MM                 

inhibitory                    0.9999999999974989^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Enzyme_inhibitor      

X-ray structure               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/X-ray_crystallography 

energy                        0.9999999999997726^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Energy                

ligand                        0.9999719647476947^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Ligand                

inhibitors                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Enzyme_inhibitor      

CDK2                          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cyclin-dependent_kinase_2

colorectal                    0.9998553461772195^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Colorectal_cancer     

conformation                  0.545274091715313^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Protein_structure     

b3lyp                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Hybrid_functional     

MM                            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Molecular_mechanics   

receptor                      0.9999999998922249^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Receptor_(biochemistry)

OPLS                          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/OPLS                  

CDK2                          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cyclin-dependent_kinase_2

HOMO                          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/HOMO/LUMO             

interaction energy            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Interaction_energy    

inhibitors                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Enzyme_inhibitor      

cyclin-dependent kinase       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cyclin-dependent_kinase

CDK2                          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cyclin-dependent_kinase_2

DFT                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Density_functional_theory

force field                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Force_field_(chemistry)

simulation                    0.9930885589399461^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Computer_simulation   

molecular docking             1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Docking_(molecular)   

inhibitor                     0.9926096797461779^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Enzyme_inhibitor      

ovarian                       0.999999990134711^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Ovarian_cancer        

